Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 8/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CCR2 | P41597 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.36 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26637720 | 1.00 | OPRM1 (0.41) | OPRM1ALDH1A1CCR2OPRK1OPRD1 | |
| SCHEMBL26637740 | 0.84 | CHRNA1 (0.39) | OPRM1ALDH1A1CCR2 | |
| SCHEMBL26637741 | 0.83 | LMNA (0.41) | OPRM1ALDH1A1OPRK1OPRD1SLC22A1 | |
| SCHEMBL31436667 | 0.83 | LMNA (0.41) | OPRM1ALDH1A1OPRK1OPRD1SLC22A1 | |
| SCHEMBL26637713 | 0.77 | CCR2 (0.37) | ALDH1A1CCR2SLC6A4KCNH2 | |
| SCHEMBL26637850 | 0.75 | ALDH1A1 (0.39) | OPRM1ALDH1A1CCR2OPRK1OPRD1 | |
| SCHEMBL31436670 | 0.75 | ALDH1A1 (0.39) | OPRM1ALDH1A1CCR2OPRK1OPRD1 | |
| SCHEMBL26637710 | 0.75 | OPRM1 (0.54) | OPRM1OPRK1OPRD1SLC22A1SLC6A4 | |
| SCHEMBL31436663 | 0.75 | OPRM1 (0.54) | OPRM1OPRK1OPRD1SLC22A1SLC6A4 | |
| SCHEMBL28202864 | 0.73 | OPRM1 (0.56) | OPRM1OPRK1OPRD1SLC22A1SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119486999-A | Azetidine compounds, pharmaceutical compositions thereof, methods of preparation and their use in the treatment of CNS disorders | 伊科诺姆有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119486999-A | Azetidine compounds, pharmaceutical compositions thereof, methods of preparation and their use in the treatment of CNS disorders | 伊科诺姆有限公司 | 2025-02-18 | — | — | CN | disclosed |